You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》泉源堂大藥房遞上市申請 傳籌3億美元
內地智慧零售藥房泉源堂大藥房日前已向聯交所提交主板上市申請,聯席保薦人為花旗及海通國際。外電引述消息指,泉源堂目標集資約2億至3億美元。

初步招股文件顯示,泉源堂於中國經營全渠道零售藥房業務,目前已設立369間線下零售藥房及38間線上藥房,截至2020年底止與逾1,000家製藥企業合作,藥房SKU數量超過3萬種。去年度公司錄得虧損1.55億元人民幣,較2019年的1.66億元人民幣收窄。

中生製藥(01177.HK)為其股東,透過附屬QYT及裕勢持有公司上市前合共近33.4%股份。另外,美國投資公司海納國際、上海方正韓投股權投資、重慶國資委旗下和亞投資及景誠(成都)股權投資基金等,均為上市前投資者。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account